Lasa Supergenerics Share Price
Small Cap | Chemicals | NSE: LASA | BSE: 540702
₹22.11 
-0.69 (-3.03 %)
Last Updated: 24 Feb 2025 04:01 PM
BEARISH
Overview
Open (₹) 22.50
High (₹) 22.50
Low (₹) 21.84
Prev. Close (₹) 22.80
Volume 1,881
VWAP (₹) 21.96
ROCE (%) -8.24
Industry P/E 58.62
TTM P/E -7.02
P/B Ratio 1.15
Market Cap (₹) Cr.110.92
Dividend Yield (%)--
EPS (₹) -4.34
ROE-22.49%
Sales Growth (%) -19.47
Profit Growth (%)-43.73
Day Range
22.5022.50
52 Week Range
19.0033.94
Historical Returns
Returns (6M)
-25.9 %
Returns (1Y)
-29.56 %
Returns (3Y)
-49.17 %
Returns (5Y)
-53.45 %
Returns (6M)
-25.9 %
Returns (1Y)
-29.56 %
Returns (3Y)
-49.17 %
Returns (5Y)
-53.45 %
SWOT Analysis
- Growth in Net Profit Margin (QoQ)
- Growth in Annual Net Profit with increasing Profit Margin (YoY)
Technicals
Technical Rating
BEARISHRSI 39.39
MFI 53.24
ATR 1.72
Commodity Channel Index -114.26
ROC125 -21.62
ROC21 -10.05
Williams %R -77.64
Resistance & Support
| Type | Resistance 1 | Resistance 2 | Resistance 3 | PP | Support 1 | Support 2 | Support 3 |
|---|---|---|---|---|---|---|---|
| Current | 22.46 | 22.81 | 23.12 | 22.15 | 21.80 | 21.49 | 21.14 |
| Week Ago | 22.91 | 23.85 | 24.40 | 22.36 | 21.42 | 20.87 | 19.93 |
| Month Ago | 26.38 | 26.81 | 27.03 | 26.16 | 25.73 | 25.51 | 25.08 |
EMA & SMA
22.11
Current Price
Bullish Moving Averages
1
Bearish Moving Averages
19
5 Day 21.83
9 Day 23.19
10 Day 23.21
12 Day 23.84
14 Day 24.13
20 Day 24.54
26 Day 25.00
50 Day 26.15
100 Day 26.32
200 Day 25.73
Deals & Announcements
Bulk and Block Deals
| Client Name | Deal Type | Action | Date | Avg. Price | Quantity | Exchange |
|---|---|---|---|---|---|---|
| SHREE VASUDEV EXIM | bulk | Buy | 25 Aug, 2021 | ₹81.85 | 3,38,428 | BSE |
| SHREE VASUDEV EXIM | bulk | Sell | 24 Aug, 2021 | ₹80.27 | 50,510 | BSE |
| SHREE VASUDEV EXIM | bulk | Buy | 24 Aug, 2021 | ₹80.45 | 2,69,761 | BSE |
Insider Trading
| Date | Name | Action | Avg. Price | Quantity | Deal Value |
|---|---|---|---|---|---|
| 05 Apr, 2023 | Vineeta Hitesh Wadhwani | Disposal | ₹22.00 | 58,500 | BSE |
| 05 Apr, 2023 | Vineeta Hitesh Wadhwani | Acquisition | ₹40.03999929999766665888886296 | 1,71,428 | BSE |
| 05 Apr, 2023 | Omkar Pravin Herlekar | Acquisition | ₹40.03999998236220555769107601 | 90,71,429 | BSE |
| 05 Apr, 2023 | Shivanand Gajanan Hegde | Acquisition | ₹40.04000236923441420679108737 | 1,85,714 | BSE |
| 01 Jul, 2022 | OMKAR PRAVIN HERLEKAR | Invoke | ₹29.45838824690187522399738414 | 7,00,343 | BSE |
| 05 Feb, 2022 | OMKAR PRAVIN HERLEKAR | Invoke | ₹0.000002314944494575853554759317536 | 21,59,879 | BSE |
Corporate Actions
| Announcement Date | Subject | Ex - Date | Record Date |
|---|---|---|---|
| 11 Apr, 2022 | Rs.0.2500 per share(2.5%)Final Dividend | 16 Sept, 2022 | 01 Jan, 1970 |
| 31 May, 2021 | Rs.0.2500 per share(2.5%)Final Dividend | 15 Sept, 2021 | 01 Jan, 1970 |
Announcements
| Date | Source | Detail |
|---|---|---|
| 22 Feb, 2025 | NSE India | Lasa Supergenerics Limited has informed the Exchange regarding Proceedings of Extraordinary General Meeting held on February 22, 2025 |
| 13 Feb, 2025 | BSE India | Pursuant to Regulation 29 and 30 of SEBI (Listing obligation and disclosure requirements) Regulations, 2015, we would like to inform you that the Board of Directors in their meeting held today which was commenced at 02.00 p.m. and concluded at 06.00 p.m. inter- alia have considered and approved the following: \r\n1. The statement of unaudited Financial Results of the Company for the quarter ended on December 31, 2024.\r\n\r\n2. Limited Review Report from Statutory Auditor for the quarter ended on December 31, 2024.\r\n |
| 13 Feb, 2025 | NSE India | Lasa Supergenerics Limited has informed the Exchange regarding Board meeting held on February 13, 2025. |
| 13 Feb, 2025 | NSE India | Lasa Supergenerics Limited has submitted to the Exchange, the financial results for the period ended December 31, 2024. |
| 11 Feb, 2025 | NSE India | General Updates: Corrigendum to the Notice of EGM scheduled to be held on 22.02.2025 |
| 11 Feb, 2025 | BSE India | The Company issued Notice of Extra -Ordinary General Meeting to the shareholders for the EGM to be held on Saturday, 22.02.2025 at 9.30 AM through video conference/other Audio visual means to transact the special business as set out in the EGM. below points to be considered as corrigendum to the noitce of EGM. |
| 05 Feb, 2025 | NSE India | LASA SUPERGENERICS LIMITED has informed the Exchange about Board Meeting to be held on 13-Feb-2025 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended December 2024 . |
| 05 Feb, 2025 | BSE India | Lasa Supergenerics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2025 ,inter alia, to consider and approve Pursuant to Regulation 29 of the Securities and Exchange Board of the India (Listing Obligation and Disclosure Requirement) Regulation, 2015 notice is hereby given that Meeting of the Board of Directors of the Company is scheduled to be held on Thursday, February 13, 2025, inter alia;\r\n1. To consider, approve and take on records unaudited financial results of the Company along with the Limited Review Report for the quarter ended on December 31, 2024.\r\n\r\n2. To discuss any other matter with the permission of the Chairperson.\r\nIn accordance with the provisions of SEBI (Prohibition of Insider Trading) Regulations, 2015 and Company's Code of Conduct, the Trading Window shall continue to remain closed till 48 hours after the declaration of the unaudited financial results of the Company for the quarter ended December 31, 2024.\r\n |
| 30 Jan, 2025 | NSE India | Lasa Supergenerics Limited has informed the Exchange regarding Notice of Extraordinary General Meeting to be held on February 22, 2025 |
| 30 Jan, 2025 | BSE India | Pursuant to Reg 30 of SEBI (LODR) Regulation 2015, we wish to inform you that the EOGM of the company will be held on saturday, February 22, 2025 at 9.30 AM (IST) through video conferencing/other audio-visual means.(VC)/(OAVM). |
Board Meetings
| Purpose | Details | Meeting Date | Broadcast Date |
|---|---|---|---|
| Quarterly Results | -- | 06 Feb, 2025 | 13 Feb, 2025 |
| Others | Inter-alia, to consider 1. The issue of warrants. 2. Proposal of fund raising by way of equity shares through rights issue. 3. Other business matters. | 23 Jan, 2025 | 28 Jan, 2025 |
| To consider issue of Warrants | (Cancelled) Postponed Board Meeting | 23 Jan, 2025 | 24 Jan, 2025 |
| Quarterly Results | -- | 07 Nov, 2024 | 14 Nov, 2024 |
| Quarterly Results | -- | 07 Aug, 2024 | 14 Aug, 2024 |
| Audited Results | -- | 27 May, 2024 | 30 May, 2024 |
| Quarterly Results | -- | 06 Feb, 2024 | 13 Feb, 2024 |
| Quarterly Results | -- | 07 Nov, 2023 | 10 Nov, 2023 |
| Quarterly Results | -- | 09 Aug, 2023 | 14 Aug, 2023 |
| Audited Results | (Revised) | 30 May, 2023 | 07 Jun, 2023 |
Share Holding Pattern
| Owner Name | Dec, 2024 | Sept, 2024 | Jun, 2024 | Mar, 2024 | Dec, 2023 |
|---|
About Lasa Supergenerics
Lasa Supergenerics is a Public Limited Listed company incorporated on 11/11/2016 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24233MH2016PLC274202 and registration number is 274202. Currently Company is involved in the business activities of Manufacture of veterinary preparations. Company’s Total Operating Revenue is Rs. 104.34 Cr. and Equity Capital is Rs. 50.10 Cr. for the Year ended 31/03/2024. Read More
Parent Organisation
Not Applicable
Founded
2016
Managing Director
Dr. Omkar Pravin Herlekar
NSE Symbol
LASA
Lasa Supergenerics Management
| Name | Designation |
|---|---|
| Dr. Omkar Pravin Herlekar | Chairman & Managing Director |
| Mr. Umesh S Pawar | Executive Director |
| Mr. Ajay Sukhwani | Independent Director |
| Ms. Manali Bhagtani | Independent Director |
| Ms. Ekta Gurnasinghani | Independent Director |
| Mr. Hardesh Tolani | Independent Director |
Peer Comparison
| Stocks | Market Cap | Market Price | 52 Week Low-High |
|---|---|---|---|
| PidiliteInds | ₹1,48,239.81 | ₹2,761.80  ₹2,795.70(-1.21%) | ₹2,490.000 - ₹3,414.400 |
| Guj.Fluoro | ₹48,324.11 | ₹3,754.35  ₹3,704.30(1.35%) | ₹2,480.000 - ₹4,875.000 |
| Apar Ind | ₹40,360.92 | ₹6,448.50 ₹6,433.45(0.23%) | ₹5,158.200 - ₹11,024.950 |
| Himadri Chem | ₹28,285.47 | ₹446.70 ₹456.95(-2.24%) | ₹272.800 - ₹688.500 |
| CleanScience | ₹15,116.91 | ₹1,280.45 ₹1,303.10(-1.74%) | ₹1,244.450 - ₹1,690.000 |
FAQs on Lasa Supergenerics
What is the share price of Lasa Supergenerics?
The share price of Lasa Supergenerics on 24 Feb, 2025 is ₹ 22.11.
What is 52W high and 52W low share price of Lasa Supergenerics?
The highest and lowest 52W share prices of Lasa Supergenerics are ₹ 40.950 and ₹ 19.000
What is the market cap of Lasa Supergenerics?
The market capitalization of Lasa Supergenerics as of 24 Feb, 2025 is ₹ 110.92 Crores
What is the P/E ratio of Lasa Supergenerics?
The current P/E ratio of Lasa Supergenerics as of 24 Feb, 2025 is 58.62
What is the PB ratio of Lasa Supergenerics?
The PB ratio of Lasa Supergenerics as of 24 Feb, 2025 is 1.15
Top Gainers
948IHFL26I
IBHFL NCD186
₹845.00
₹705.00 (0.20%)
GREAVESCOT
Greaves
₹281.85
₹234.90 (0.20%)
ASHSI
Ashirwd Stl
₹45.66
₹38.05 (0.20%)
CAPRO
Caprola.Chem
₹62.40
₹52.00 (0.20%)
Top Losers
DHANBANK
Dhanalak.Bnk
₹32.19
₹35.97 (-0.11%)
08MPD
08MPD
₹8.66
₹9.62 (-0.10%)
BALTE
BalurghtTran
₹27.13
₹31.24 (-0.13%)
DARSHANORNA
Darshan Orna
₹4.57
₹5.07 (-0.10%)
Market Indices
Sensex
₹78,699.07
₹78,472.48 (0.00%)